Unlock the full potential of transcriptomics at industrial scale. ScreenSeq™, Evotec’s proprietary 3' mRNA–focused platform, delivers unbiased, high-quality gene expression profiles across more than 10,000 genes in a streamlined and automated 384-well format. Built for modern drug discovery, ScreenSeq™ powers everything from large-scale screening to hit validation, SAR exploration, and toxicogenomic insights.

With millions of transcriptome profiles generated to date and over 150 biological models established, ScreenSeq™ offers a uniquely scalable and integrated solution—from cell biology through sequencing to bioinformatic interpretation. Generate AI-ready data, accelerate decision-making, and de-risk your portfolio with a platform proven to advance next-generation therapeutic discovery.